SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001062993-21-001180
Filing Date
2021-02-10
Accepted
2021-02-10 15:40:47
Documents
1
Group Members
ADVENT LIFE SCIENCES FUND II LPSHAHZAD MALIK

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A formsc13da.htm SC 13D/A 116030
  Complete submission text file 0001062993-21-001180.txt   117665
Mailing Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND 44 (0) 207 932 2120
Advent Life Sciences LLP (Filed by) CIK: 0001601364 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Subject) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90503 | Film No.: 21613542
SIC: 2834 Pharmaceutical Preparations